NCT05487833Unknown4 期
Comparison of Insulin and Standard Management in Hypertriglyceridemic Acute Pancreatitis in Patients Without Diabetes
适应症
干预措施
试验速览
- 阶段
- 4 期
- 入组人数
- 30
- 主要终点
- %triglyceride reduction
研究概览
简要总结
To compare the efficacy of infusion containing insulin and infusion without insulin on reduction of triglycerides in acute hypertriglyceridemic pancreatitis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •acute pancreatitis
- •triglycerides > 15 mmol/l
排除标准
- •diabetes on peroral therapy or insulin
- •blood glucose > 11 mmol/l
- •pregnancy
研究组 & 干预措施
standard management
Placebo Comparator
干预措施: standard treatment (Other)
insulin
Experimental
干预措施: insulin (Biological)
结局指标
主要结局
%triglyceride reduction
时间窗: after 18 hours of treatment
change in triglycerides, expressed as % of initial value
次要结局
- incidence of hypoglycemia(during treatment with insulin, up to day 5)
研究者
Jakob Gubensek
Principal investigator
University Medical Centre Ljubljana
相似试验
已完成
不适用
Comparison of two regimens of Insulin and Insulin-Metformin in glycemic control of type 2 Diabetic patients after CABG surgeryType 2 diabetes.Non-insulin dependent diabetesIRCT201008084365N5Mazandaran University of Medical Sciences100
尚未招募
不适用
Comparison of two different techniques(insulin bolus vs glucose insulin infusion) to control blood glucose levels during surgeryCTRI/2017/12/011037Dr Arun P
已完成
不适用
Clinical Study for the Comparison of Blood Insulin Pharmacokinetics in different insulin pen needlesType 1 and 2 diabetesJPRN-UMIN000004469Department of Medicine, Metabolism and Endocrinology, Juntendo University Graduate School of Medicine12
已完成
4 期
Lantus in the Treatment of Type 1 Diabetes ChildrenType 1 DiabetesNCT00206401Baylor College of Medicine60
已完成
不适用
Comparison of the effects of insulin monotherapy and combination therapy with ipragliflozin and insulin on glucose toxicity in type 2 diabetes mellitus : a randomized controlled trialType 2 diabetesJPRN-UMIN000018784Osaka university medical hospital40